Walgreens (NYSE: WAG) (Nasdaq: WAG) had July sales of $6.39 billion, an increase of 6.1 percent from $6.02 billion for the same month in fiscal 2013. Total front-end sales increased 1.4 percent in July compared with the same month in fiscal 2013, while comparable store front-end sales increased 1.1 percent. Customer traffic in comparable stores decreased 2.6 percent while basket size increased 3.7 percent. Prescriptions filled at comparable stores increased by 3.7 percent in July and increased 4.3 percent on a calendar day-shift adjusted basis. July 2014 had one additional Thursday and one fewer Monday compared with July 2013. These calendar shifts negatively impacted prescriptions filled at comparable stores by 0.6 percentage point. July pharmacy sales increased by 9.5 percent. Comparable store pharmacy sales increased 7.6 percent and increased by a calendar day-shift adjusted 8.2 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 0.6 percentage point. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.7 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 66.5 percent of total sales for the month. Sales in comparable stores increased by 5.2 percent in July. Calendar day shifts negatively impacted total comparable sales by 0.4 percentage point. Generic drug introductions in the last 12 months negatively impacted total comparable sales by 1.1 percentage points. Calendar 2014 year-to-date sales for the first seven months were $44.51 billion, an increase of 5.9 percent from $42.02 billion in 2013. Fiscal 2014 year-to-date sales for the first 11 months were $70.03 billion, an increase of 6.0 percent from $66.06 billion in fiscal 2013. Walgreens opened eight stores during July, including one relocation, and closed 30. Nearly all of the July store closings were part of the company’s previously announced efforts to optimize its asset base by closing a total of 76 drugstores.